Cargando…
Design, Synthesis and Biological Evaluation of Multi-Target Anti-Cancer Agent PYR26
This study investigates the synthesis of a new compound, PYR26, and the multi-target mechanism of PYR26 inhibiting the proliferation of HepG2 human hepatocellular carcinoma cells. PYR26 significantly inhibits the growth of HepG2 cells (p < 0.0001) and this inhibition has a concentration effect. T...
Autores principales: | He, Sirong, He, Peiting, Wu, Haojing, Feng, Yao, Situ, Jiejin, Chen, Yiling, Du, Junxi, Qin, Jin, Lv, Pengcheng, Chen, Kun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10138507/ https://www.ncbi.nlm.nih.gov/pubmed/37108294 http://dx.doi.org/10.3390/ijms24087131 |
Ejemplares similares
-
[Pyr(1)]Apelin-13((1–12)) Is a Biologically Active ACE2 Metabolite of the Endogenous Cardiovascular Peptide [Pyr(1)]Apelin-13
por: Yang, Peiran, et al.
Publicado: (2017) -
Structural basis of reiterative transcription from the pyrG and pyrBI promoters by bacterial RNA polymerase
por: Shin, Yeonoh, et al.
Publicado: (2020) -
MAS-NMR of [Pyr(13)][Tf(2)N] and [Pyr(16)][Tf(2)N] Ionic Liquids Confined to Carbon Black: Insights and Pitfalls
por: Merz, Steffen, et al.
Publicado: (2021) -
Molecular Mechanisms in the Activation of Abscisic Acid Receptor PYR1
por: Dorosh, Lyudmyla, et al.
Publicado: (2013) -
CEPR2 phosphorylates and accelerates the degradation of PYR/PYLs in Arabidopsis
por: Yu, Zipeng, et al.
Publicado: (2019)